Why Innotox Formulation Innovation Reduces Irritation
For years, the aesthetic medicine industry grappled with a persistent challenge: how to maintain neurotoxin efficacy while minimizing skin irritation. Traditional botulinum toxin type A formulations required complex reconstitution processes and contained stabilizers like human serum albumin, which contributed to adverse reactions in 12-18% of users according to 2022 clinical data. The breakthrough came through …
Why Innotox Formulation Innovation Reduces Irritation Read More »